BENVENUTI, MANUELA
 Distribuzione geografica
Continente #
EU - Europa 3.040
NA - Nord America 2.905
AS - Asia 595
SA - Sud America 40
AF - Africa 17
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.609
Nazione #
US - Stati Uniti d'America 2.894
GB - Regno Unito 793
IE - Irlanda 555
CN - Cina 426
IT - Italia 415
UA - Ucraina 295
SE - Svezia 256
RU - Federazione Russa 215
DE - Germania 182
FR - Francia 136
SG - Singapore 111
FI - Finlandia 98
BR - Brasile 34
VN - Vietnam 21
CZ - Repubblica Ceca 20
BE - Belgio 16
NL - Olanda 16
CI - Costa d'Avorio 11
PL - Polonia 11
IN - India 10
AU - Australia 7
CA - Canada 7
CH - Svizzera 5
AT - Austria 4
EU - Europa 4
EG - Egitto 3
GR - Grecia 3
JP - Giappone 3
LU - Lussemburgo 3
PT - Portogallo 3
AR - Argentina 2
ES - Italia 2
HK - Hong Kong 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KR - Corea 2
MK - Macedonia 2
PA - Panama 2
PH - Filippine 2
QA - Qatar 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ID - Indonesia 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PS - Palestinian Territory 1
RO - Romania 1
SA - Arabia Saudita 1
TN - Tunisia 1
TR - Turchia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 6.609
Città #
Southend 712
Dublin 555
Chandler 305
Fairfield 305
Jacksonville 241
Santa Clara 241
Ashburn 179
Woodbridge 167
Wilmington 137
Siena 115
Cambridge 112
Seattle 112
Houston 111
Princeton 109
Ann Arbor 101
Menlo Park 87
Nanjing 87
Beijing 77
Boardman 56
Fremont 55
Singapore 49
Helsinki 47
San Mateo 37
New York 35
San Diego 35
Sesto Fiorentino 33
Shanghai 32
Moscow 28
Nanchang 28
Dong Ket 21
Florence 19
London 19
Milan 17
Shenyang 17
Venezia 17
Brussels 16
Changsha 15
Lancaster 15
Jiaxing 14
Kunming 14
Tianjin 14
Brno 13
Munich 12
Abidjan 11
Jinan 11
Amsterdam 10
Hangzhou 10
Norwalk 10
Rome 10
Düsseldorf 9
Guangzhou 9
San Francisco 9
Zhengzhou 9
Hebei 8
West Jordan 8
Dearborn 7
Ningbo 7
Olomouc 7
Chicago 6
Gdynia 6
Prato 6
Frankfurt am Main 5
Martellago 5
Taizhou 5
Auburn Hills 4
Bari 4
Columbus 4
Haikou 4
Los Angeles 4
Paris 4
Philadelphia 4
Pisa 4
Pontedera 4
Redwood City 4
Toronto 4
Vienna 4
Canberra 3
Changchun 3
Edinburgh 3
Empoli 3
Genoa 3
Hanover 3
Hefei 3
Kilburn 3
Luxembourg 3
Luzzara 3
Nuremberg 3
Pistoia 3
Roorkee 3
Shijiazhuang 3
Tappahannock 3
Torino 3
Wroclaw 3
Acton 2
Almada 2
Athens 2
Atlanta 2
Bitonto 2
Bologna 2
Budapest 2
Totale 4.692
Nome #
VNRX-5133 (Taniborbactam), a broad-spectrum inhibitor of serine- And metallo-β-lactamases, restores activity of cefepime in enterobacterales and Pseudomonas aeruginosa 242
Crystal structure of the Pseudomonas aeruginosa BEL-1 extended-spectrum β-lactamase and its complexes with moxalactam and imipenem 178
SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model 162
X-ray Crystal Structure of the Acinetobacter baumannii OXA-24/40 Class D Carbapenemase Inhibited by NXL104 151
XAS of dilute biological samples 147
Amino-thiadiazole as innovative inhibitors of human glutaminyl cyclase, a validated target towards Alzheimer disease 147
Atomic-Resolution Structure of a Class C β-Lactamase and Its Complex with Avibactam 144
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- And Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections 142
Crystal structure of the extended-spectrum β-lactamase BEL-1, in native form and in complex with imipenem and moxalactam. 140
The first structure of a bacterial class B acid phosphatase reveals further structural heterogeneity among phosphatases of the haloacid dehalogenase fold 140
Crystal structure of AphA class B acid phosphatase/phosphotransferase from E. coli 139
A structure-based proposal for the catalytic mechanism of the bacterial acid phosphatase AphA belonging to the DDDD superfamily of phosphohydrolases 138
The structure of the human glutaminyl cyclase–SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders 137
Boric acid and acetate anion binding to subclass B3 metallo-β-lactamase BJP-1 provides clues for mechanism of action and inhibitor design 134
1,2,4-Triazole-3-Thione analogues with a 2-Ethylbenzoic acid at position 4 as VIM-type metallo-β-Lactamase inhibitors 131
Crystallization and preliminary crystallographic analysis of the hydroxyquinol 1,2-dioxygenase from Nocardioides simplex 3E: a novel dioxygenase involved in the biodegradation of polychlorinated aromatic compounds 131
Crystallization of soluble proteins in vapor diffusion for x-ray crystallography 129
Structural characterisation of a new heparinisable material based on ethylene/vinyl alcohol/vinyl acetate terpolymer and a poly(amido-amine) 127
1,2,4-Triazole-3-thione compounds with a 4-ethyl alkyl/aryl sulfide substituent are broad-spectrum metallo-β-lactamase inhibitors with re-sensitization activity 126
Sulfated hyaluronic acid as heparin-like material: physicochemical and biological characterization 125
Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC  beta-Lactamases 120
null 120
Crystal structure of the narrow-spectrum OXA-46 class D beta-lactamase: relationship between active-site lysine carbamylation and inhibition by polycarboxylates 119
Characterization of the metallocenter of rabbit skeletal muscle AMP deaminase. Evidence for a dinuclear zinc site 119
The evolutionarily conserved trimeric structure of CutA1 proteins suggests a role in signal transduction 118
The soluble Y115E-Y117E variant of human glutaminyl cyclase is a valid target for X-ray and NMR screening of inhibitors against Alzheimer disease 118
Sulfated hyaluronic acid as heparin-like material: physico-chemical and biological characterization 116
From an inactive prokaryotic SOD homologue to an active protein through site-directed mutagenesis 116
Evolution to carbapenem -hydrolyzing activity in noncarbapenemase class D beta-lactamase OXA-10 by rational protein design 114
High-Resolution Crystal Structure of the Subclass B3 Metallo-beta-Lactamase BJP-1: Rational Basis for Substrate Specificity and Interaction with Sulfonamides 114
4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors 114
Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases 112
Structural Insights into the Catalytic Mechanism of the Bacterial Class B Phosphatase AphA Belonging to the DDDD Superfamily of Phosphohydrolases 112
Sulfated hyaluronic acid as heparin-like material: physico-chemical and biological characterization 112
Crystal structure and mutational analysis of FUS-1 (OXA-85), a class D beta-lactamase from Fusobacterium nucleatum subsp. polymorphum 112
ANT2681: SAR studies leading to the identification of a metallo-β-lactamase inhibitor with potential for clinical use in combination with meropenem for the treatment of infections caused by NDM-Producing enterobacteriaceae 112
Discovery of ANT3310, a novel broad-spectrum serine β-Lactamase inhibitor of the diazabicyclooctane class, which strongly potentiates meropenem activity against carbapenem-resistant enterobacterales and acinetobacter baumannii 109
Structure of the extended-spectrum beta-lactamase TEM-72 inhibited by citrate 98
Preparation, physico-chemical and biological characterization of heparinizable materials 96
Crystal structure of Enterococcus faecalis Thymidylate synthase 95
Structural and functional characterization of two new class D beta-lactamases: OXA-46 and OXA-48 94
Acid-base properties and complexing abilities of an aminodicarboxylic acid and its corresponding polymer 94
Metallo-enzyme mechanism from accurate structural data 91
Evolution to carbapenem-hydrolyzing activity in class D β-lactamases by rational protein design 91
New trends in blood compatible materials 91
Derivati solfatati dell'acido ialuronico come prodotto eparino-simili: caratterizzazione chimico-fisica e biologica 85
Adsorption of metal ions from sulphuric acid solution by chelating resins 81
Crystallographic studies of new human Thymidylate synthase inhibitors 78
Materials containing heparin complexing polymers, physicochemical characterization and compatibility 77
Crystallographic studies of new human Thymidylate synthase inhibitors 74
Expression, purification, crystallization and preliminary X-ray characterization of the class B acid phosphatase (AphA) from Escherichia coli 74
Crystallographic studies of new human Thymidylate synthase inhibitors. 71
Derivati solfatati dell'acido ialuronico come prodotti eparino-simili: caratterizzazione chimico-fisica e biologica 70
Calorimetric study of macromolecular complex formation between heparin and poly(amido-amine)s. 65
Synthesis of two novel heparinizable polymeric materials (EVAPA-45 and EVAPA) for hemodialysis membranes 62
Synthesis of two novel heparinizable polymeric materials starting from an ethylene/vinyl alcohol/vinyl acetate terpolymer 62
null 54
New macromolecular ligands. Basicity and complexing properties of monomeric and polymeric dicarboxylic aminoacids 53
Synthesis and chemical characterization: characterization of biomaterials in contact with blood 52
Large size chelate rings in copper(II) complexes with triamine 49
Structural and functional characterization of two new class D beta-lactamase: OXA-46 and OXA-48 47
Optimization of 1,2,4-Triazole-3-thiones toward Broad-Spectrum Metallo-β-lactamase Inhibitors Showing Potent Synergistic Activity on VIM- and NDM-1-Producing Clinical Isolates 36
Totale 6.707
Categoria #
all - tutte 22.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020556 0 0 0 0 0 56 79 138 94 92 24 73
2020/2021973 32 98 22 72 76 141 38 157 120 77 56 84
2021/2022771 38 99 69 49 79 27 34 39 27 78 62 170
2022/20231.080 70 77 128 136 116 238 17 104 131 12 27 24
2023/2024904 43 16 60 34 53 206 292 24 2 30 29 115
2024/2025820 98 105 133 112 270 102 0 0 0 0 0 0
Totale 6.707